Yawei Dai, Yong Li, Xiaoliang Yang, Yu Zhou, Yukang Mao, Yang Chuanxi, Peng Li, Kun Zhao
{"title":"沉默纤连蛋白基因(FN1)可通过核受体共激活因子4 (NCOA4)依赖的方式,通过铁蛋白吞噬介导的铁凋亡改善nacl诱导的心脏纤维化。","authors":"Yawei Dai, Yong Li, Xiaoliang Yang, Yu Zhou, Yukang Mao, Yang Chuanxi, Peng Li, Kun Zhao","doi":"10.1111/bph.70205","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>High-salt diet (HSD) induces heart damage, including cardiac fibrosis, independent of blood pressure. Exploring the underlying molecular mechanisms is of significant clinical value.</p><p><strong>Experimental approach: </strong>Male rats or neonatal rat cardiac fibroblasts (NRCFs) were treated with HSD or sodium chloride (NaCl) to induce cardiac fibrosis in vivo and in vitro, respectively. Exosome high-throughput sequencing was performed from exosomes isolated from culture supernatants of NRCFs treated with/without NaCl.</p><p><strong>Key results: </strong>First, HSD and NaCl induced myocardial fibrosis and ferroptosis in vivo and in vitro, respectively. The results of exosome high-throughput sequencing, along with validation experiments, showed that NaCl increased fibronectin gene (Fn1) expression via post-transcriptional regulation in NRCFs. Cardiac-specific silencing of Fn1attenuated HSD-induced cardiac fibrosis and ferroptosis, while Fn1 overexpression counteracted these effects. Also, GW4869-mediated exosome depletion reduced extracellular FN-1 but did not rescue NaCl-induced cardiac fibrosis. Moreover, silencing Fn1 inhibited NaCl-induced increase of nuclear receptor coactivator 4 (NCOA4). Fn1 loss exacerbated NCOA4 degradation. Next, inhibition of NOCA4-mediated ferritinophagy improved HSD-induced cardiac fibrosis, whereas NCOA4 overexpression hampered the antifibrotic effects of silencing Fn1in NaCl-induced NRCFs. Besides, autophagy inhibitor 3-MA ameliorated NaCl-induced cardiac fibrosis and ferroptosis, indicating that autophagy was essential for NCOA4-mediated ferroptosis.</p><p><strong>Conclusion and implications: </strong>Overall, our finding identified that silencing Fn1 possessed beneficial effects against NaCl-induced cardiac fibrosis through downregulating the ferroptosis of NRCFs, which was attributed to the inhibition of NOCA4-mediated ferritinophagy.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":" ","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Silencing the fibronectin gene (FN1) improves NaCl-induced cardiac fibrosis via ferritinophagy-mediated ferroptosis in a nuclear receptor coactivator 4 (NCOA4)-dependent manner.\",\"authors\":\"Yawei Dai, Yong Li, Xiaoliang Yang, Yu Zhou, Yukang Mao, Yang Chuanxi, Peng Li, Kun Zhao\",\"doi\":\"10.1111/bph.70205\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>High-salt diet (HSD) induces heart damage, including cardiac fibrosis, independent of blood pressure. Exploring the underlying molecular mechanisms is of significant clinical value.</p><p><strong>Experimental approach: </strong>Male rats or neonatal rat cardiac fibroblasts (NRCFs) were treated with HSD or sodium chloride (NaCl) to induce cardiac fibrosis in vivo and in vitro, respectively. Exosome high-throughput sequencing was performed from exosomes isolated from culture supernatants of NRCFs treated with/without NaCl.</p><p><strong>Key results: </strong>First, HSD and NaCl induced myocardial fibrosis and ferroptosis in vivo and in vitro, respectively. The results of exosome high-throughput sequencing, along with validation experiments, showed that NaCl increased fibronectin gene (Fn1) expression via post-transcriptional regulation in NRCFs. Cardiac-specific silencing of Fn1attenuated HSD-induced cardiac fibrosis and ferroptosis, while Fn1 overexpression counteracted these effects. Also, GW4869-mediated exosome depletion reduced extracellular FN-1 but did not rescue NaCl-induced cardiac fibrosis. Moreover, silencing Fn1 inhibited NaCl-induced increase of nuclear receptor coactivator 4 (NCOA4). Fn1 loss exacerbated NCOA4 degradation. Next, inhibition of NOCA4-mediated ferritinophagy improved HSD-induced cardiac fibrosis, whereas NCOA4 overexpression hampered the antifibrotic effects of silencing Fn1in NaCl-induced NRCFs. Besides, autophagy inhibitor 3-MA ameliorated NaCl-induced cardiac fibrosis and ferroptosis, indicating that autophagy was essential for NCOA4-mediated ferroptosis.</p><p><strong>Conclusion and implications: </strong>Overall, our finding identified that silencing Fn1 possessed beneficial effects against NaCl-induced cardiac fibrosis through downregulating the ferroptosis of NRCFs, which was attributed to the inhibition of NOCA4-mediated ferritinophagy.</p>\",\"PeriodicalId\":9262,\"journal\":{\"name\":\"British Journal of Pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bph.70205\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bph.70205","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Silencing the fibronectin gene (FN1) improves NaCl-induced cardiac fibrosis via ferritinophagy-mediated ferroptosis in a nuclear receptor coactivator 4 (NCOA4)-dependent manner.
Background and purpose: High-salt diet (HSD) induces heart damage, including cardiac fibrosis, independent of blood pressure. Exploring the underlying molecular mechanisms is of significant clinical value.
Experimental approach: Male rats or neonatal rat cardiac fibroblasts (NRCFs) were treated with HSD or sodium chloride (NaCl) to induce cardiac fibrosis in vivo and in vitro, respectively. Exosome high-throughput sequencing was performed from exosomes isolated from culture supernatants of NRCFs treated with/without NaCl.
Key results: First, HSD and NaCl induced myocardial fibrosis and ferroptosis in vivo and in vitro, respectively. The results of exosome high-throughput sequencing, along with validation experiments, showed that NaCl increased fibronectin gene (Fn1) expression via post-transcriptional regulation in NRCFs. Cardiac-specific silencing of Fn1attenuated HSD-induced cardiac fibrosis and ferroptosis, while Fn1 overexpression counteracted these effects. Also, GW4869-mediated exosome depletion reduced extracellular FN-1 but did not rescue NaCl-induced cardiac fibrosis. Moreover, silencing Fn1 inhibited NaCl-induced increase of nuclear receptor coactivator 4 (NCOA4). Fn1 loss exacerbated NCOA4 degradation. Next, inhibition of NOCA4-mediated ferritinophagy improved HSD-induced cardiac fibrosis, whereas NCOA4 overexpression hampered the antifibrotic effects of silencing Fn1in NaCl-induced NRCFs. Besides, autophagy inhibitor 3-MA ameliorated NaCl-induced cardiac fibrosis and ferroptosis, indicating that autophagy was essential for NCOA4-mediated ferroptosis.
Conclusion and implications: Overall, our finding identified that silencing Fn1 possessed beneficial effects against NaCl-induced cardiac fibrosis through downregulating the ferroptosis of NRCFs, which was attributed to the inhibition of NOCA4-mediated ferritinophagy.
期刊介绍:
The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries.
Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues.
In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.